rs72647375
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_213655.5(WNK1):c.759+16_759+18dupCTT variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0629 in 1,613,104 control chromosomes in the GnomAD database, including 3,750 homozygotes. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.084 ( 660 hom., cov: 32)
Exomes 𝑓: 0.061 ( 3090 hom. )
Consequence
WNK1
NM_213655.5 intron
NM_213655.5 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.0360
Publications
0 publications found
Genes affected
WNK1 (HGNC:14540): (WNK lysine deficient protein kinase 1) This gene encodes a member of the WNK subfamily of serine/threonine protein kinases. The encoded protein may be a key regulator of blood pressure by controlling the transport of sodium and chloride ions. Mutations in this gene have been associated with pseudohypoaldosteronism type II and hereditary sensory neuropathy type II. Alternatively spliced transcript variants encoding different isoforms have been described but the full-length nature of all of them has yet to be determined.[provided by RefSeq, May 2010]
WNK1 Gene-Disease associations (from GenCC):
- neuropathy, hereditary sensory and autonomic, type 2AInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P, Ambry Genetics
- pseudohypoaldosteronism type 2CInheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- hereditary sensory and autonomic neuropathy type 2Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP6
Variant 12-754339-A-ACTT is Benign according to our data. Variant chr12-754339-A-ACTT is described in ClinVar as Benign. ClinVar VariationId is 310547.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.139 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| WNK1 | ENST00000340908.9 | c.759+15_759+16insCTT | intron_variant | Intron 1 of 27 | 5 | NM_213655.5 | ENSP00000341292.5 | |||
| WNK1 | ENST00000315939.11 | c.759+15_759+16insCTT | intron_variant | Intron 1 of 27 | 1 | NM_018979.4 | ENSP00000313059.6 |
Frequencies
GnomAD3 genomes AF: 0.0835 AC: 12692AN: 152090Hom.: 659 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
12692
AN:
152090
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0576 AC: 14315AN: 248314 AF XY: 0.0554 show subpopulations
GnomAD2 exomes
AF:
AC:
14315
AN:
248314
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0607 AC: 88675AN: 1460896Hom.: 3090 Cov.: 88 AF XY: 0.0594 AC XY: 43168AN XY: 726760 show subpopulations
GnomAD4 exome
AF:
AC:
88675
AN:
1460896
Hom.:
Cov.:
88
AF XY:
AC XY:
43168
AN XY:
726760
show subpopulations
African (AFR)
AF:
AC:
4801
AN:
33480
American (AMR)
AF:
AC:
2057
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
AC:
2427
AN:
26134
East Asian (EAS)
AF:
AC:
4
AN:
39700
South Asian (SAS)
AF:
AC:
897
AN:
86258
European-Finnish (FIN)
AF:
AC:
3428
AN:
52484
Middle Eastern (MID)
AF:
AC:
226
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
71168
AN:
1111964
Other (OTH)
AF:
AC:
3667
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
4541
9082
13624
18165
22706
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
2632
5264
7896
10528
13160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0835 AC: 12712AN: 152208Hom.: 660 Cov.: 32 AF XY: 0.0821 AC XY: 6111AN XY: 74420 show subpopulations
GnomAD4 genome
AF:
AC:
12712
AN:
152208
Hom.:
Cov.:
32
AF XY:
AC XY:
6111
AN XY:
74420
show subpopulations
African (AFR)
AF:
AC:
5886
AN:
41516
American (AMR)
AF:
AC:
1050
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
AC:
318
AN:
3472
East Asian (EAS)
AF:
AC:
3
AN:
5188
South Asian (SAS)
AF:
AC:
46
AN:
4830
European-Finnish (FIN)
AF:
AC:
738
AN:
10604
Middle Eastern (MID)
AF:
AC:
12
AN:
294
European-Non Finnish (NFE)
AF:
AC:
4355
AN:
68002
Other (OTH)
AF:
AC:
185
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
588
1176
1764
2352
2940
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
136
272
408
544
680
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Pseudohypoaldosteronism type 2C;C2752089:Neuropathy, hereditary sensory and autonomic, type 2A Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Oct 06, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
Jan 16, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
Mar 10, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Pseudohypoaldosteronism type 2A Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.